An autosomal dominant nonsyndromic deafness that has material basis in variation in the chromosome region 3q22.
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
The documentation for autosomal dominant nonsyndromic hearing loss 18 is limited primarily due to its rarity and the absence of identified genes. Because this condition affects fewer individuals, systematic clinical studies and comprehensive phenotypic characterizations have not been feasible. This can lead to feelings of isolation and frustration for those affected, but ongoing research may yield more insights in the future.
To navigate your care, consider seeking a specialist in genetic disorders or a clinical geneticist who has experience with hereditary hearing loss. They can provide guidance on potential genetic counseling and testing options. Additionally, while there are no specific patient organizations for this condition, resources like the National Organization for Rare Disorders (NORD) at rarediseases.org can offer support and information. Engaging with clinical trials may also provide access to cutting-edge research and treatment options.
Currently, there is one active clinical trial related to autosomal dominant nonsyndromic hearing loss 18. This trial may offer insights into potential management strategies and the condition itself. For more information, you can explore the trial details at ClinicalTrials.gov using the following link: https://clinicaltrials.gov/search?cond=autosomal%20dominant%20nonsyndromic%20hearing%20loss%2018. While there are no orphan drugs designated for this condition, participation in clinical trials can be a valuable opportunity for patients.
Actionable guidance for navigating care for autosomal dominant nonsyndromic hearing loss 18
To navigate your care, consider seeking a specialist in genetic disorders or a clinical geneticist who has experience with hereditary hearing loss. They can provide guidance on potential genetic counseling and testing options. Additionally, while there are no specific patient organizations for this condition, resources like the National Organization for Rare Disorders (NORD) at rarediseases.org can offer support and information. Engaging with clinical trials may also provide access to cutting-edge research and treatment options.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.